Core Viewpoint - The company TianKang (301263.SZ) has received a drug registration certificate from the National Medical Products Administration for Methimazole tablets, a medication used to treat hyperthyroidism [1] Company Summary - TianKang's wholly-owned subsidiary, Shandong Huabo Kaisheng Biotechnology Co., Ltd., has recently obtained the registration certificate for Methimazole tablets [1] - Methimazole is classified as a thiazole anti-thyroid drug that inhibits the activity of thyroid peroxidase (TPO), thereby blocking the synthesis of thyroid hormones T4 and T3 [1] Industry Summary - Methimazole tablets are commonly used for treating hyperthyroidism, particularly in patients with mild hyperthyroidism and those with mild to moderate goiter [1] - The drug is also indicated for preventing thyroid storm in patients undergoing radioactive iodine treatment [1]
泰恩康(301263.SZ)子公司获甲巯咪唑片药品注册证书